0002080382-25-000001.txt : 20250807 0002080382-25-000001.hdr.sgml : 20250807 20250807141036 ACCESSION NUMBER: 0002080382-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250807 DATE AS OF CHANGE: 20250807 EFFECTIVENESS DATE: 20250807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rhinal Therapeutics Inc. CENTRAL INDEX KEY: 0002080382 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-554015 FILM NUMBER: 251193172 BUSINESS ADDRESS: STREET 1: 732 S 6TH ST STREET 2: 4248 CITY: LAS VEGAS STATE: NV ZIP: 89101 BUSINESS PHONE: 7029816980 MAIL ADDRESS: STREET 1: 732 S 6TH ST STREET 2: 4248 CITY: LAS VEGAS STATE: NV ZIP: 89101 D 1 primary_doc.xml X0708 D LIVE 0002080382 Rhinal Therapeutics Inc. 732 S 6TH ST 4248 LAS VEGAS NV NEVADA 89101 7029816980 NEVADA None None Corporation true 2023 Lawrence Fox 732 S 6TH ST 4248 Las Vegas NV NEVADA 89101 Executive Officer Director CEO, President and Director Frank Puglisi 732 S 6TH ST 4248 Las Vegas NV NEVADA 89101 Executive Officer Director Chief Clinical Officer and Director Austin Panhans 732 S 6TH ST 4248 Las Vegas NV NEVADA 89101 Executive Officer Chief Financial Officer Robert Clayborough 732 S 6TH ST 4248 Las Vegas NV NEVADA 89101 Executive Officer Director Chief Scientific Officer and Director Mike George 732 S 6TH ST 4248 Las Vegas NV NEVADA 89101 Director Biotechnology No Revenues 06b false 2025-07-28 false true false 0 1000000 20000 980000 false 1 0 0 200000 true false Rhinal Therapeutics Inc. /s/ Austin Panhans Austin Panhans CFO 2025-08-07